Can Statins Cause Neuropathy or Tingling in Hands and Feet?

An illustration showing the effects of statins on muscle cells and nerves.

Can Statins Cause Neuropathy or Tingling in Hands and Feet?

Rarely, if at all. The largest studies find little or no rise in nerve damage among statin users, but individual cases of statin-linked neuropathy have been reported, and symptoms often improve after the statin is stopped. If your hands or feet started tingling on a statin, it is worth checking, because other causes are far more common.

Peripheral neuropathy means damage to the long nerves that run out to the hands and feet. It usually starts in the toes and feet with tingling, numbness, burning or a “pins and needles” feeling, and it can later reach the hands. Doctors often call it polyneuropathy when many nerves are affected at once.

No randomized trial has been designed to test whether statins cause neuropathy. The evidence comes from observational studies that compare people who take statins with people who do not, plus side effect reports from heart trials.

What the Data Show

Two meta-analyses, which pool the results of many studies, reach the same answer. One systematic review with two meta-analyses found no statistically significant link between statins and new neuropathy. In people without diabetes, the odds were about 24% higher in statin users, but that result could easily be chance. In people with diabetes, the same meta-analysis found odds about 18% lower, also not significant. The authors noted that the studies varied a lot.

A second meta-analysis of 9 studies and 150,556 patients found a nonsignificant increase of about 26% and concluded there was no significant link. Its authors rated the quality of the evidence as low.

Blinded heart trials point the same way. A 2026 analysis of 19 double-blind trials with 123,940 participants, followed for a median of 4.5 years, concluded that the trial data do not support a causal link between statins and peripheral neuropathy.

There is a catch. As a review of lipids and neuropathy points out, neuropathy was never a planned outcome in the major statin trials, so no one went looking for it with nerve tests. A big effect would likely have shown up. A small one, or one that hits only a few sensitive people, could still be missed.

Why Do Some Studies Say Statins Cause Neuropathy?

The worry started with a 2002 Danish case-control study of 166 people with nerve damage that had no known cause. Statin users had about 3.7 times the odds of neuropathy, and the odds were much higher among people who had used statins for 2 years or more. The authors concluded that long-term statin use may substantially increase the risk.

The same research group then repeated the study with more data: 370 confirmed cases and 7,400 controls from 1999 to 2013. This time statin use was not linked to neuropathy, whether people had used statins recently, for 5 years or more, or at high intensity.

A Dutch study of 333 patients with unexplained nerve damage and 283 controls went further: people with neuropathy were about 44% less likely to have taken a statin, and the odds of neuropathy fell the longer people had used one. Its review of 13 earlier studies found results that conflicted widely, and most had flaws in how they were done.

The most careful look at nerves came from a Danish study that tested 57 new statin users and 46 non-users at the start and after 1 year, with nerve conduction tests and skin biopsies. No one developed full neuropathy. But 5 statin users developed nerve-like symptoms, and those 5 had lost some vibration sense compared with statin users who had no symptoms. The authors wrote that they could not rule out effects on nerves in some people.

How Rare Is Statin Neuropathy, and What Does It Feel Like?

A drug-safety review in Prescrire put the risk at about 1 person in 10,000 treated for a year. The reported cases looked like ordinary neuropathy: loss of feeling, weaker reflexes, and in some people marked weakness in the affected limbs. Kidney failure and diabetes appeared to raise the risk.

That means if 10,000 people take a statin for a year, about 1 might develop nerve damage from it. Neuropathy from other causes is far more common than that.

The usual symptoms of peripheral neuropathy, from any cause, are:

SymptomWhere it usually starts
Tingling or pins and needlesToes and soles of the feet
Numbness or a “wearing socks” feelingFeet, later hands
Burning or electric pain, often worse at nightFeet and lower legs
Poor balance or unsteady walkingLegs

Which Statins Cause Peripheral Neuropathy?

No statin has been shown to be safer for nerves than another. In a small Turkish study of 50 patients on atorvastatin or rosuvastatin, nerve testing found no significant difference between the two drugs. In the larger Danish repeat study, high-intensity statin use was not linked to neuropathy.

The same Turkish study found nerve damage on testing in 33 of 50 statin users (66%) and in none of 50 people who had never taken one, and the severity rose with time on atorvastatin.

So if you have read that rosuvastatin or atorvastatin is the “neuropathy statin,” the research does not support picking one out.

How Long Does It Take for Statins to Cause Neuropathy?

There is no set timeline. In the 2002 Danish study, the link was strongest after 2 or more years of use. In a Danish cohort of people with type 2 diabetes, new statin users had about a 31% higher risk of diabetic nerve damage during their first year, and that extra risk was gone after more than 2 years.

Do Statins Cause Neuropathy in People With Diabetes?

The same Danish diabetes cohort followed about 260,000 people with new type 2 diabetes for a median of 6.2 years. Nerve damage occurred at nearly the same rate in each group: 4.0 per 1,000 people per year in new statin users, 3.8 in long-term users and 3.8 in non-users. The authors concluded statins are unlikely to raise or lower the risk, though a small early risk could not be excluded.

The pooled analysis above found no link in people with diabetes either.

Does Statin Neuropathy Go Away After Stopping?

Often, yes, when the statin was really the cause. The Prescrire review reported that once other causes of neuropathy have been ruled out, stopping the statin often leads to improvement. A review of statin nerve and muscle side effects also notes that stopping the statin, or switching to a different cholesterol drug, can avoid these side effects.

Stopping and watching what happens is one of the few ways to tell whether the statin was to blame. Do that with your doctor, not on your own, especially if you have had a heart attack or stroke.

Is It Muscle Pain or Nerve Pain?

Muscle problems are the common statin side effect. The review of statin nerve and muscle effects says side effects in nerves and muscles together make up about two thirds of all statin side effects. These include cramps, muscle aches, weakness, and rare immune and muscle breakdown conditions. Peripheral neuropathy is listed separately.

The difference matters. Muscle symptoms are usually aching, heaviness or cramps in the thighs, shoulders or calves. Nerve symptoms are tingling, numbness or burning that starts in the feet. They have different causes and different tests.

What Else Causes Tingling in Hands and Feet?

Before blaming a statin, it is worth checking the common causes:

  • Diabetes or prediabetes, the leading cause
  • Low vitamin B12, more likely with long-term metformin or acid-blocking drugs, or with a vegan diet
  • Heavy alcohol use
  • Low thyroid function and kidney disease
  • Pinched nerves in the neck or back, or carpal tunnel syndrome if only the hands tingle

A few blood tests, such as glucose or A1c, B12 and thyroid levels, cover most of these.

Dr. Kumar’s Take

The honest answer is that statins are a rare cause of tingling hands and feet, not a common one. The early study that raised the alarm was not confirmed when the same researchers repeated it with more data. But “rare” is not “never,” and the big heart trials were not built to find nerve damage. If your symptoms began on a statin, your report counts as real data.

Nerve symptoms are a good reason to look harder, not to shrug. The cause is far more often blood sugar, B12, alcohol or a pinched nerve, and those are fixable. If the workup is clean, a supervised break from the statin is a fair test, and the decision about whether and how to restart is yours to make with your doctor.

Practical Takeaways

  • Note when the tingling started and whether it began after a statin was started or the dose went up.
  • Get the common causes checked: blood sugar or A1c, vitamin B12, thyroid and kidney function.
  • Tell muscle aches apart from nerve symptoms. Aching and cramps point to muscles. Tingling, numbness and burning point to nerves.
  • Do not count on switching brands. No statin has been shown to be easier on nerves.
  • Do not stop on your own if you have had a heart attack, stroke or stent. Plan any break with your doctor.
  • Seek care quickly for weakness, trouble walking, tingling that spreads fast, or symptoms on one side only.

FAQs

Can statins cause tingling in your feet?

It is possible but rare. Large studies and pooled analyses find little or no rise in neuropathy among statin users, and one drug-safety review estimated about 1 case per 10,000 people per year. Diabetes, low B12 and alcohol are much more common causes.

Can rosuvastatin cause tingling in hands and feet?

Rosuvastatin has not been shown to carry more nerve risk than other statins. A small study comparing it with atorvastatin found no significant difference on nerve testing. Any statin could rarely be involved, so the workup is the same.

Is statin neuropathy permanent?

Often it is not. A drug-safety review reported that stopping the statin often leads to improvement once other causes are ruled out. How fully and how fast nerves recover varies from person to person.

Do statins cause nerve damage in people with diabetes?

A Danish study of about 260,000 people with type 2 diabetes found nerve damage at about the same rate with or without statins. There was a small rise in the first year on a statin that disappeared after 2 years.

Should I stop my statin if my feet tingle?

Talk to your doctor first. Testing for the common causes comes first, and a supervised break can show whether the statin is involved. Stopping suddenly carries its own risks if you have had a heart attack or stroke.

Bottom Line

Statins are an uncommon cause of tingling and numbness in the hands and feet. The large studies find little or no added risk, but rare cases happen and often improve after the statin is stopped. Check blood sugar, B12, thyroid and kidney function first, and plan any change to your statin with your doctor.

References

  1. Wannarong T, et al. Statins and the risk of polyneuropathy: a systematic review and two meta-analyses. Muscle Nerve, 2022 pubmed.ncbi.nlm.nih.gov
  2. Wang M, et al. The association between statins exposure and peripheral neuropathy risk: a meta-analysis. J Clin Pharm Ther, 2021 pubmed.ncbi.nlm.nih.gov
  3. Cholesterol Treatment Trialists' Collaboration. Adverse effects attributed to statin therapy in product labels: meta-analysis of double-blind trials. Lancet, 2026 pubmed.ncbi.nlm.nih.gov
  4. Pasha R, et al. Lipids, lipid-lowering therapy, and neuropathy: a narrative review. Clin Ther, 2022 pubmed.ncbi.nlm.nih.gov
  5. Gaist D, et al. Statins and risk of polyneuropathy: a case-control study. Neurology, 2002 pubmed.ncbi.nlm.nih.gov
  6. Svendsen TK, et al. Statins and polyneuropathy revisited: case-control study in Denmark, 1999-2013. Br J Clin Pharmacol, 2017 pubmed.ncbi.nlm.nih.gov
  7. Warendorf JK, et al. Statins do not increase risk of polyneuropathy: a case-control study and literature review. Neurology, 2019 pubmed.ncbi.nlm.nih.gov
  8. Svendsen TK, et al. Statin use and peripheral nerve function: a prospective follow-up study. Basic Clin Pharmacol Toxicol, 2020 pubmed.ncbi.nlm.nih.gov
  9. Prescrire International. Peripheral neuropathy and statins. Prescrire Int, 2007 pubmed.ncbi.nlm.nih.gov
  10. Kristensen FP, et al. Statin therapy and risk of polyneuropathy in type 2 diabetes: a Danish cohort study. Diabetes Care, 2020 pubmed.ncbi.nlm.nih.gov
  11. Özdemir IH, et al. Peripheral polyneuropathy in patients receiving long-term statin therapy. Turk Kardiyol Dern Ars, 2019 pubmed.ncbi.nlm.nih.gov
  12. Attardo S, et al. Statins neuromuscular adverse effects. Int J Mol Sci, 2022 pubmed.ncbi.nlm.nih.gov

Get Dr. Kumar's free health protocols

Evidence-based playbooks from Dr. Ravi Kumar, MD, a board-certified neurosurgeon, plus a weekly research review. Enter your email and I'll send you the relevant protocol.

By subscribing, you agree to receive emails from The Dr Kumar Discovery. You can unsubscribe at any time. Privacy Policy

The Dr Kumar Discovery Podcast
Podcast

The Dr Kumar Discovery

Where science meets common sense. Practical, unbiased answers to today's biggest health questions.

Browse all episodes →